First Trust NYSE Arca Biotechnology Index Fund is a ETF series of First Trust Exchange-Traded Fund (series S000012478). Net assets $2.3B as of 2026-03-31. Index fund.
Showing 15 of 32 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Moderna Inc | — | $119.4M | 526.15% |
| United Therapeutics Corporation | — | $98.9M | 435.81% |
| Alkermes PLC | — | $96.1M | 423.52% |
| Gilead Sciences Inc. | — | $92.8M | 408.86% |
| Axsome Therapeutics Inc. | — | $88.2M | 388.55% |
| Amgen Inc. | — | $87.0M | 383.26% |
| Corcept Therapeutics Inc. | — | $86.7M | 381.87% |
| Krystal Biotech Inc | — | $79.7M | 351.04% |
| Biogen Inc | — | $78.8M | 347.13% |
| Exelixis, Inc. | — | $78.5M | 345.98% |
| Neurocrine Biosciences Inc | — | $78.2M | 344.66% |
| Regeneron Pharmaceuticals, Inc. | — | $78.2M | 344.59% |
| Vertex Pharmaceuticals Incorporated | — | $77.6M | 341.93% |
| Biomarin Pharmaceutical Inc. | — | $77.3M | 340.41% |
| Argenx SE | — | $74.7M | 329.15% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $2.3B |
| 2025-12-31 | $1.3B |
| 2025-09-30 | $1.1B |
| 2025-06-30 | $1.0B |
| 2025-03-31 | $1.1B |
| 2024-12-31 | $1.1B |
| 2024-09-30 | $1.2B |
| 2024-06-30 | $1.1B |